Postal Ballot clears re-appointment of Bhartia brothers as MD and Jt MD

Management Changes View source PDF Explain this filing

JUBLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹864.70

prior close

₹863.95

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.2%-0.3% vs market

Pharmaceuticals peers, median of 175sector+0.0%-0.1% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Smallcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.6

10m

+0.3

15m

+0.1

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1+0.2-0.3+0.0-0.1

Next day

+0.3-0.4+0.7-0.6+0.8

+0.0+0.1-0.1-0.2+0.2

+1.4+0.6+0.9-0.2+1.6

+4.4+0.3+4.1-0.4+4.9

+3.5+0.2+3.3-0.7+4.2

+1.6+0.7+0.9-0.6+2.2

15d

+15.6+1.2+14.4+1.6+14.0

+24.1-0.1+24.3+1.7+22.5

+9.0-4.8+13.8-4.2+13.2

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 175Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jubilant Pharmova shareholders approved re-appointment of Priyavrat Bhartia as Managing Director (99.81% in favor) and Arjun Shanker Bhartia as Joint Managing Director (99.87% in favor) via postal ballot on August 17, 2026. About 12.72 crore shares were polled, representing 79.9% of outstanding shares. Promoter group voted 100 percent in favor of both resolutions.

Likely market impact

Existing promoter-family leadership at MD and Joint MD level re-confirmed by shareholders with overwhelming margin. No leadership change expected.